These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Neuroleptic malignant syndrome and low-dose olanzapine. Suh H; Bronson B; Martin R Am J Psychiatry; 2003 Apr; 160(4):796. PubMed ID: 12668376 [No Abstract] [Full Text] [Related]
23. Fever, delirium, autonomic instability, and monocytosis associated with olanzapine. Robinson RL; Burk MS; Raman S J Postgrad Med; 2003; 49(1):96. PubMed ID: 12865583 [No Abstract] [Full Text] [Related]
24. Olanzapine motor side effect. Daniel DG; Egan M; Issa F Neuropsychopharmacology; 1997 Jan; 16(1):88-90. PubMed ID: 8981393 [No Abstract] [Full Text] [Related]
25. Olanzapine-induced thrombocytopenia in association with idiopathic thrombocytopenic purpura. Bachmann S; Schröder J; Pantel J; Mundt C; Zorn M; Witzens M; Egerer G Br J Psychiatry; 1998 Oct; 173():352. PubMed ID: 9926044 [No Abstract] [Full Text] [Related]
26. Benefits of olanzapine as first-line schizophrenia therapy. Cohen LJ Am J Health Syst Pharm; 1999 Aug; 56(15):1559-60, 1563-4. PubMed ID: 10478999 [No Abstract] [Full Text] [Related]